一个回顾式图表分析,比较每年和两年一次的乳腺造影检测率
Pavan Patel1, Hifza Sakhi1, Devaki Kalvapudi1
1Transitional Year, Northeast Georgia Medical Center, Gainesville, GA, USA.
Journal of clinical medicine research
|January 6, 2025
概括
与每两年一次的查相比,每年一次的乳腺扫描可以在较早的阶段发现乳腺癌. 这项研究发现,年度查与较低的BI-RADS分类和癌症阶段有关,这表明早期检测率有所改善.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 乳腺癌是美国妇女死亡的主要原因.
- 组织之间的乳房镜检查频率建议有所不同.
- 这项研究比较了每年和两年一次的乳腺癌检测率.
研究的目的:
- 分析机构数据,比较乳腺癌检测率.
- 评估乳房镜查频率与癌症特征之间的相关性.
主要方法:
- 对2219名被诊断患有乳腺癌的25-74岁女性进行了回顾性图表审查.
- 分析包括BI-RADS,受体状态,瘤特征和查频率在内的变量.
- 统计分析以确定查频率与患者/瘤特征之间的关联.
主要成果:
- BI-RADS分类,ER状态和PR状态与查频率有关.
- 每两年进行查的患者显示N2节点参与度较低.
- 西班牙裔/拉丁裔患者和目前的吸烟者有不同的查频率.
结论:
- 每年进行的乳房造影与较低的BI-RADS阶段有关.
- 年度查与乳腺癌诊断的较低阶段有关.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.8K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
177
相关概念视频
Cancer Survival Analysis
290
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
290
Actuarial Approach
36
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
36
Comparing the Survival Analysis of Two or More Groups
81
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
81
Interpreting Run Charts
39
Run charts, essentially line graphs plotted over time, serve as fundamental yet effective tools for process analysis. They chronicle data sequentially, facilitating the identification of trends, shifts, or cyclical movements. This graphical representation is instrumental in determining whether a process is stable or exhibits signs of potential instability indicative of special cause variation. In the healthcare domain, run charts depict infection rates over time, enabling hospitals to monitor...
39
Receiver Operating Characteristic Plot
60
A ROC (Receiver Operating Characteristic) plot is a graphical tool used to assess the performance of a binary classification model by illustrating the trade-off between sensitivity (true positive rate) and specificity (false positive rate). By plotting sensitivity against 1 - specificity across various threshold settings, the ROC curve shows how well the model distinguishes between classes, with a curve closer to the top-left corner indicating a more accurate model. The area under the ROC curve...
60
Kaplan-Meier Approach
51
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
51
